USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
INHIBIKASE THERAPEUTICS
Address:
3350 Riverwood Pkwy
Atlanta, GA 30339-6451
Phone:
N/A
URL:
EIN:
126340724
DUNS:
828325899
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $565,846.00 2

Award List:

PML antiviral for AIDS

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$265,846.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Inhibikase Therapeutics is an early stage biopharmaceutical company developing a novel strategy for treating infectious disease that occurs in AIDS patients. The Company seeks to create an anti-infective product for tr eatment of JC viral infection, which leads… More

System for multidimensional analysis of growth and migration of neurons and neuro

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Milton H. Werner – 678-392-3419
Abstract:
DESCRIPTION (provided by applicant): Inhibikase Therapeutics is a clinical stage, biopharmaceutical company that has developed a host- targeted mechanism of action to treat AIDS-related and drug-induced progressive multifocal leukoencephalopathy (PML). PMLis a demyelinating disease of the central… More